Editorial

Protean Manifestations of Metabolic Syndrome

Authors: Ranjodh S. Gill, MD, FACP

Abstract

Metabolic syndrome (MBS) is a clustering of multiple medical risk factors. It is defined by the National Cholesterol Education Program's Adult Treatment Panel III as a constellation of abdominal obesity (waist circumference >102 cm in men and >88 cm in women), hypertriglyceridemia (>150), low HDL cholesterol (<40 in men and <50 in women), high blood pressure (>130/85) and elevated fasting glucose (>100).1,2 Metabolic syndrome is deemed to exist when a patient has three out of these five risk factors. These risk factors combine to confer a higher likelihood for the development of cardiovascular disease and diabetes mellitus.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.
 
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752.
 
3. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
 
4. Tsai CH, Li TC, Lin CC. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J 2008;101:900–905.
 
5. Rios MS, Caro JF, Carraro R, et al. The Metabolic Syndrome at the Beginning of the XXIst Century: A Genetic and Molecular Approach. New York, Elsevier, 2005.
 
6. Morgagni GB. De sedibus et causis morborum per anatomen indagatis. G Ital Cardiol 1985;15:456–457.
 
7. Reaven G, Strom TK, Fox B. Syndrome X: Overcoming the Silent Killer That Can Give You a Heart Attack. New York, Simon & Schuster, 2001.
 
8. Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991;121:1274–1282.
 
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Education Survey. JAMA 2002;287:356–359.
 
10. Jeppesen J, Hansen TW, Ramussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population based study. J Am Coll Cardiol 2007;49:2112–2119.